These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1357909)

  • 21. [Mechanisms of cell death in Alzheimer's disease].
    Luquin MR; Martínez-Vila E; Saldise L
    Rev Med Univ Navarra; 1997; 41(1):34-45. PubMed ID: 9527712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonists.
    Gauthier S; Leblanc R; Robitaille Y; Quirion R; Carlsson G; Beaulieu M; Bouchard R; Dastoor D; Ervin F; Gauthier L
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):394-402. PubMed ID: 2878712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of neurotransmitter abnormalities in Alzheimer's disease.
    Katzman R; Brown T; Fuld P; Thal L; Davies P; Terry R
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():279-86. PubMed ID: 2873637
    [No Abstract]   [Full Text] [Related]  

  • 24. Co-existence between receptors, carriers, and second messengers on astrocytes grown in primary cultures.
    Hansson E
    Neurochem Res; 1989 Sep; 14(9):811-9. PubMed ID: 2574421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in neurobiology: Part III. Effectors of transmitter action.
    Hyman SE
    Psychosomatics; 1988; 29(4):373-8. PubMed ID: 2906447
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurotransmitters in the cerebral cortex.
    Jones EG
    J Neurosurg; 1986 Aug; 65(2):135-53. PubMed ID: 2873211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging.
    Roth GS; Joseph JA; Mason RP
    Trends Neurosci; 1995 May; 18(5):203-6. PubMed ID: 7610488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptides in Alzheimer's and in Parkinson's disease.
    Constantinidis J; Bouras C; Vallet PG
    Mt Sinai J Med; 1988 Jan; 55(1):102-15. PubMed ID: 2894608
    [No Abstract]   [Full Text] [Related]  

  • 29. [A new tool in neurochemistry--quantitative autoradiography of receptors].
    Skangiel-Kramska J
    Postepy Biochem; 1983; 29(3-4):393-5. PubMed ID: 6148746
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neuropeptides and Alzheimer's disease].
    Jiménez A; Astarloa R; Morales B
    Neurologia; 1991 Jan; 6(1):17-24. PubMed ID: 1677810
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of neurotransmitters in the pathogenesis and treatment of Alzheimer's disease].
    Reinikainen K; Riekkinen PJ
    Duodecim; 1983; 99(6):379-87. PubMed ID: 6135595
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biochemical analysis of neurotransmitters and receptors in prefrontal cortex of post-mortem brains from schizophrenic patients].
    Toru M; Watanabe S; Nishikawa T; Noda K; Mitsushio H; Mataga N; Takashima M; Shibuya H
    Seishin Shinkeigaku Zasshi; 1982; 84(12):947-61. PubMed ID: 6134296
    [No Abstract]   [Full Text] [Related]  

  • 33. Alzheimer's disease.
    Gottfries CG
    Gerontology; 1986; 32 Suppl 1():98-101. PubMed ID: 2874102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotransmitter deficits in Alzheimer's disease: criteria for significance.
    Greenwald BS; Mohs RC; Davis KL
    J Am Geriatr Soc; 1983 May; 31(5):310-6. PubMed ID: 6132940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurotransmitter anomalies in Alzheimer's disease].
    Berger B
    Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin and GHRH: mood and behavioral regulation.
    Rubinow DR; Post RM; Davis CL; Doran AR
    Adv Biochem Psychopharmacol; 1987; 43():137-52. PubMed ID: 2884816
    [No Abstract]   [Full Text] [Related]  

  • 37. Glutamate transmission and toxicity in Alzheimer's disease.
    Greenamyre JT; Maragos WF; Albin RL; Penney JB; Young AB
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):421-30. PubMed ID: 2900537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts.
    Zilles K; Qü M; Schleicher A; Schroeter M; Kraemer M; Witte OW
    Arzneimittelforschung; 1995 Mar; 45(3A):361-6. PubMed ID: 7763327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amnesia and Alzheimer's disease: which neurotransmitter system is responsible?
    Wenk GL
    Neurobiol Aging; 1988; 9(5-6):640-1. PubMed ID: 2905431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Is Alzheimer's senile dementia associated with the phenomena of reactive synaptogenesis in the hippocampus?].
    Represa A; Duyckaerts C; Tremblay E; Hauw JJ; Ben-Ari Y
    C R Acad Sci III; 1988; 306(19):575-7. PubMed ID: 2902911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.